CMS doubles the number of drugs subject to inflation remedies

The Biden administration identified 43 drugs subject to rebates from manufacturers to Medicare and lower coinsurance rates for beneficiaries starting July 1 -- more than double the current number. Host Kelly Hooper talks with Robert King about the Centers for Medicare and Medicaid Services' decision. Learn more about your ad choices. Visit megaphone.fm/adchoices